PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival	Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, breast cancer, breast disorder, breast neoplasm, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung cancer, lung disorder, lung neoplasm, metastatic malignant neoplasm, neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Recruiting	Not applicable	2026-07-14		NCT06896162

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eli Lilly and Company	370
UNC Lineberger Comprehensive Cancer Center	125

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Lineberger Comprehensive Cancer Center, University of North Carolina	Chapel Hill	United States	2